Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Protein kinase domain containing protein | 0.0112311 | 1 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.00388468 | 0.0937245 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.00388468 | 0.0937245 | 1 |
Brugia malayi | Transforming growth factor beta like domain containing protein | 0.00689676 | 0.465303 | 0.465303 |
Echinococcus granulosus | tissue type plasminogen activator | 0.00388468 | 0.0937245 | 0.201427 |
Loa Loa (eye worm) | bone morphogenic protein 6 | 0.00689676 | 0.465303 | 0.465303 |
Onchocerca volvulus | 0.00424306 | 0.137935 | 1 | |
Echinococcus multilocularis | anti dorsalizing morphogenetic protein 1a | 0.00689676 | 0.465303 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00388468 | 0.0937245 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00831982 | 0.640855 | 0.640855 |
Loa Loa (eye worm) | hypothetical protein | 0.0112311 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.00388468 | 0.0937245 | 0.0937245 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.00388468 | 0.0937245 | 0.5 |
Brugia malayi | Fibroblast growth factor family protein | 0.00831982 | 0.640855 | 0.640855 |
Giardia lamblia | Hypothetical protein | 0.00831982 | 0.640855 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.00388468 | 0.0937245 | 0.201427 |
Echinococcus granulosus | anti dorsalizing morphogenetic protein 1a | 0.00689676 | 0.465303 | 1 |
Brugia malayi | Fibroblast growth factor family protein | 0.00831982 | 0.640855 | 0.640855 |
Leishmania major | hypothetical protein, conserved | 0.00388468 | 0.0937245 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.00388468 | 0.0937245 | 0.5 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.00388468 | 0.0937245 | 0.0937245 |
Loa Loa (eye worm) | hypothetical protein | 0.00388468 | 0.0937245 | 0.0937245 |
Brugia malayi | Kringle domain containing protein | 0.00388468 | 0.0937245 | 0.0937245 |
Loa Loa (eye worm) | hypothetical protein | 0.00831982 | 0.640855 | 0.640855 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0 % | In vivo evaluation of the compound for antimalarial activity against P. berghei in percentage when administered subcutaneously in mice | ChEMBL. | 10212135 |
Activity (functional) | = 0 % | In vivo evaluation of the compound for antimalarial activity against P. berghei in percentage when administered orally in mice | ChEMBL. | 10212135 |
Activity (functional) | = 0 % | In vivo evaluation of the compound for antimalarial activity against P. berghei in percentage when administered subcutaneously in mice | ChEMBL. | 10212135 |
Activity (functional) | = 0 % | In vivo evaluation of the compound for antimalarial activity against P. berghei in percentage when administered orally in mice | ChEMBL. | 10212135 |
IC50 (functional) | = 14 nM | In vitro evaluation of the compound for antimalarial activity against P. falciparum using chloroquine resistant K1 strain | ChEMBL. | 10212135 |
IC50 (functional) | = 14 nM | In vitro evaluation of the compound for antimalarial activity against P. falciparum using chloroquine resistant K1 strain | ChEMBL. | 10212135 |
IC50 (functional) | = 16 nM | In vitro evaluation of the compound for antimalarial activity against P. falciparum using drug resistant NF54 strain | ChEMBL. | 10212135 |
IC50 (functional) | = 16 nM | In vitro evaluation of the compound for antimalarial activity against P. falciparum using drug resistant NF54 strain | ChEMBL. | 10212135 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 10212135 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.